HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.

Autor: Schoofs T; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA., Klein F; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA. Laboratory of Experimental Immunology, Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany. Department of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne, 50937 Cologne, Germany., Braunschweig M; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA. Albert Ludwigs University of Freiburg, Freiburg, Germany., Kreider EF; Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Feldmann A; Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, Campus E14, 66123 Saarbrücken, Germany., Nogueira L; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA., Oliveira T; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA., Lorenzi JC; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA., Parrish EH; Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Learn GH; Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., West AP Jr; Division of Biology, California Institute of Technology, Pasadena, CA 91125, USA., Bjorkman PJ; Division of Biology, California Institute of Technology, Pasadena, CA 91125, USA., Schlesinger SJ; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA., Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Czartoski J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Pfeifer N; Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, Campus E14, 66123 Saarbrücken, Germany., Hahn BH; Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Caskey M; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA., Nussenzweig MC; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA. Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065, USA.
Jazyk: angličtina
Zdroj: Science (New York, N.Y.) [Science] 2016 May 20; Vol. 352 (6288), pp. 997-1001. Date of Electronic Publication: 2016 May 05.
DOI: 10.1126/science.aaf0972
Abstrakt: 3BNC117 is a broad and potent neutralizing antibody to HIV-1 that targets the CD4 binding site on the viral envelope spike. When administered passively, this antibody can prevent infection in animal models and suppress viremia in HIV-1-infected individuals. Here we report that HIV-1 immunotherapy with a single injection of 3BNC117 affects host antibody responses in viremic individuals. In comparison to untreated controls that showed little change in their neutralizing activity over a 6-month period, 3BNC117 infusion significantly improved neutralizing responses to heterologous tier 2 viruses in nearly all study participants. We conclude that 3BNC117-mediated immunotherapy enhances host humoral immunity to HIV-1.
(Copyright © 2016, American Association for the Advancement of Science.)
Databáze: MEDLINE
Externí odkaz: